2026-08-12 21:54:14 UTC#168127newspeculationanalysis
ADMA stock news
ADMA stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire14 wire items
2026-08-05 23:33:15 UTC#133685newconfirmednews
ADMA Biologics reiterates 2026 revenue guidance of $530M-$560M, announces $200M+ share buyback plan
2026-08-05 22:50:39 UTC#133512duplicateconfirmednews
ADMA Biologics Q2 adjusted EPS $0.16 misses $0.17 estimate, revenue $124.40M misses $131.66M
2026-08-05 20:05:00 UTC#132339newconfirmednews
ADMA Biologics Reports Q2 2026 EPS of 16 Cents
2026-08-04 10:36:00 UTC#122129newconfirmednews
ADMA Biologics faces securities class action lawsuit over alleged channel stuffing scheme
2026-08-03 21:32:04 UTC#119381newforecastnews
ADMA Biologics Q2 2026 Earnings Preview: Analysts Forecast $0.17 EPS and $131.66M Revenue
2026-07-31 18:41:00 UTC#111388newconfirmednews
ADMA Biologics faces securities class action lawsuit; lead plaintiff deadline set for August 10, 2026
2026-07-28 14:10:00 UTC#88180newconfirmednews
ADMA Biologics faces securities class action lawsuit over alleged financial misrepresentations; deadline Aug 10
2026-07-23 14:09:00 UTC#69745newreportednews
ADMA Biologics faces class action lawsuit over alleged channel stuffing and revenue misstatements, SueWallSt says
2026-07-21 10:17:00 UTC#56592newconfirmednews
ADMA Biologics hit with securities class action lawsuit over alleged channel stuffing scheme
2026-07-16 14:09:00 UTC#41305newconfirmednews
ADMA Biologics faces securities class action over alleged revenue inflation; lead plaintiff deadline Aug 10
2026-07-15 18:30:00 UTC#37242newconfirmednews
Mizuho maintains Outperform rating on ADMA Biologics
2026-07-14 10:21:00 UTC#29792newconfirmednews
ADMA Biologics faces securities fraud class action lawsuit over alleged channel stuffing scheme
2026-07-07 10:33:00 UTC#6541newconfirmednews